Skip to main content

All Articles

Shift to Hospital-Based Oncology Inadvertently Spurred by the 340B Drug Pricing Program

By Rosemary Frei, MSc

December 2013, Vol 3, No 8

Institute of Medicine Recommends Measures to Achieve High-Quality Cancer Care

By Rosemary Frei, MSc

December 2013, Vol 3, No 8

Checklist to Cut Your 2013 Taxes

By Andrew D. Schwartz, CPA; Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF

Financial Management, Practice Management

December 2013, Vol 3, No 8

FDA-Approved Medications Used for the Treatment of Lymphoma

December 2013, Vol 3, No 8

Clinical Trials Under Way for Pediatric, Adolescent, and Young Adult Patients with Cancer

Clinical Trials Tracker

December 2013, Vol 3, No 8

The Government Shutdown May Have Long-Ranging Effects

By Sydney Abbott, JD

December 2013, Vol 3, No 8

A Sudden Change of Course

By Teri U. Guidi, MBA, FAAMA

November 2013, Vol 3, No 7

Let the Transition Begin

By Karna W. Morrow, CPC, RCC, CCS-P, PCS

Billing and Coding, Reimbursement

November 2013, Vol 3, No 7

As many practices move from planning for to actually implementing the new code set for the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), a few things are strikingly apparent. Read More ›

Whatever Happened to Thinking?

November 2013, Vol 3, No 7

Oncology Through a Fractured Looking Glass: How to Compete?

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

November 2013, Vol 3, No 7

Page 282 of 299